New study adds to evidence of stroke and heart attack risk with some hormonal contraceptives
Certain hormonal contraceptives are associated with a higher stroke and heart attack risk, finds a large study from Denmark ...
Mineralys Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Corporate Update
Anticipate topline data from pivotal Advance-HTN trial in March 2025 and pivotal Phase 3 Launch-HTN trial in mid first half of 2025 –– ...
Clinical trial finds RNA inhibitor effectively reduces 'bad cholesterol' in patients with cardiovascular disease
The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of ...
News Medical on MSN6h
Study finds varying cardiovascular risks associated with different hormonal contraceptives
Certain hormonal contraceptives are associated with a higher stroke and heart attack risk, finds a large study from Denmark in The BMJ today that draws on prescription records to give more precise ...
The Healthy @Reader's Digest on MSN17h
OTC Medication Mistakes: Doctors Advise You To Avoid Doing These
Just because you can buy a medication over the counter doesn’t mean it’s always safe. Here’s how you should really be using ...
News Medical on MSN5h
Olpasiran significantly lowers "bad cholesterol" linked to cardiovascular risk
The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of cardiovascular events, according to results from an analysis by a Mount Sinai ...